2015 annual financial data

Karyopharm Therapeutics 2015 Net margin

Direct answer

Net margin was -47,272.4%.

Operating income was -119,076,000 USD and net income was -118,181,000 USD.
Operating cash flow was -94,029,000 USD.

Get free Karyopharm Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
250,000 USD
Operating income
-119,076,000 USD
Net income
-118,181,000 USD
Operating cash flow
-94,029,000 USD